IT & Data Management
Advent of Artificial Pancreas Technology Will Alter Lives
Innovative technology could help people with Type 1 diabetes who can't control their condition, and it will be made available to them. Additionally, the aid...
News
A Guide to Understanding Cloning
When most people hear the term ’cloning’, they immediately recollect the story of Dolly, the first sheep to be cloned. Out of 277 embryos, she...
News
Massive Life Sciences Mergers-Acquisitions To Occur In 2023
According to EY's 2023 M&A Firepower report, the life sciences sector has record levels of deal-making Firepower, which measures a company's ability to undertake M&A...
Drug Research
The AMR Action Fund Invests in BioVersys in Fight Against Drug-Resistant Bacteria
The AMR Action Fund, a public-private partnership investing in biotech companies developing antimicrobials, has invested in BioVersys AG, a clinical-stage company based in Basel, Switzerland....
Drug Research
BMS, Dragonfly Enter Exclusive License for Sixth TriNKET Immunotherapy Candidate
Bristol Myers Squibb has exercised its option under a research collaboration with Dragonfly Therapeutics, Inc, to enter into an exclusive license for a sixth TriNKET...
News
Sarepta and Catalent Expand Strategic Manufacturing Partnership with Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate
Catalent and Sarepta Therapeutics have signed a commercial supply agreement for Catalent to manufacture delandistrogene moxeparvovec (SRP-9001), Sarepta’s most advanced gene therapy candidate for the...
Drug Research
FUJIFILM Announces License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies
FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cells (iPSC), announced that it has entered an agreement to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.